Clinical trial

NMDA Modulation in Major Depressive Disorder

NCT04637620

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2017-06-01

PhasePHASE2

Study timeline

Study start (actual)2017-06-01Date precision: day

Registry last updated2025-02-19

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Major Depressive Disorderverified · MONDO: major depressive disorder

Interventions

NMDAEDRUG

SertralineDRUG · verified · RxNorm: sertraline

Placebo CapDRUG

Sponsors & collaborators

China Medical University Hospitallead sponsor

Ministry of Science and Technology, Taiwancollaborator

Mapped research locations

TaichungTaiwan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04637620 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.